Pharmahungary Group as a Hungarian SME is ready for Horizon 2020 applications and are offering innovative preclinical and clinical R&D services.
Pharmahungary Group scientific team attended the XXIII ISHR World Congress in Beijing, China
Vezics exosome isolation platform SME Instrument Phase I grant winner
Pharmahungary Group attends 24th BIO Europe convention in Copenhagen, Denmark. Meet us there!
Advanced Good Clinical Practice course, presentation by Clinical Director